Scientists

Scientists

For science to make the news in a rigorous and attractive way, good sources are needed. Because access to scientific knowledge is a citizen's right.

¿Qué me ofrece?

Help science make headlines with rigour and context. We’ll ask you for feedback on current events in your field and you can participate in the briefings we’ll organise. Need to prepare for an interview? Use our resources on science communication.

Icono
Cómo trabajamos

We’re on the lookout for controversial information about science and we will contact you for your analysis in your area. Do you want to be part of our sources? Contact us. We will not pass your contact details on to anyone else. You can find out more about how we work here.   

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Reactions: 50% chance of warming exceeding 1.5°C within seven years

At the current level of emissions, there is a 50% chance that global temperatures will exceed the 1.5°C target consistently over seven years. This is one of the forecasts in the Global Carbon Budget 2023 report, which estimates that CO2 emissions from fossil fuels will reach record highs in 2023, reaching 36.8 billion tonnes, 1.1 % more than in 2022. The report, published in the journal Earth System Science Data, shows that emissions have decreased in the EU as a whole and in the United States, while they continue to increase in India and China.

0

Reaction: gluten sensitivity may be partly due to the nocebo effect in non-coeliacs

People who do not have coeliac disease or wheat allergy sometimes reduce their gluten intake because they believe it is the cause of their gastrointestinal symptoms. A study has found that there may be a nocebo effect - negative anticipation of a substance or treatment, the opposite of the placebo effect - on gluten sensitivity in these people, so that the mere thought of ingesting gluten causes more symptoms in those who believe they are sensitive to it. The results are published in the journal The Lancet Gastroenterology & Hepatology.

0

What do we know about scientific misconduct? A guide to reporting about research integrity

According to a survey conducted in Spain, with 403 respondents from the biomedical research field, four out of ten admit to having committed some type of misconduct in their work. The press regularly reports on scandals in science. Among the most recent cases, El País reported that the CSIC has opened a disciplinary proceeding against five individuals suspected of receiving money in exchange of false affiliations. These cases of misconduct may seem isolated, but they reflect broader dysfunction of the research system. In this guide, we provide keys to better understand how these cases arise and evolve, and to cover their nuances. 

0

Reactions: four out of ten biomedical researchers in Spain admit to scientific misconduct in a study

In a recent study of the experiences of biomedical researchers in Spain, 43% of respondents admitted to having intentionally committed some form of scientific misconduct. The most frequent kind of misconduct was false authorship of scientific articles: 35% of the 403 respondents said they had been involved in some instance of it, says the study published in the journal Accountability in Research. Ten per cent of respondents reported a lack of informed consent, and 3.6 per cent admitted to having been involved at least once in falsification or manipulation of data.

0

Reaction: Social media use in young people is associated with increased risk behaviour, says review of studies

A review including 126 studies shows an association between the use of social networking sites by 10-19 year olds and increased risk behaviours, including alcohol, tobacco and other drug use, risky sexual behaviour, gambling and antisocial behaviour. According to the authors, who acknowledge that their research does not establish causality, "precautions may need to be taken in academia, government, health and education before the risks of adolescent use of social networking sites are fully understood". The findings are published in The BMJ.

0

Reaction: FDA launches investigation into possible increased risk of developing certain tumours with CAR-T therapies

The US Food and Drug Administration (FDA) has issued a statement reporting that it has received reports of T-cell tumours in patients who received various CAR-T cell treatments. As quoted in the statement, "although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action".

0

Reaction: some large earthquakes can emit signals months before they occur

According to research published in the journal Nature Communications, the magnitude 7.8 earthquake that was felt in parts of Turkey and Syria in February this year emitted detectable signals eight months before it struck. Although it is currently not possible to predict the magnitude, time and location of earthquakes in the short term, these results would indicate that some large earthquakes may show a detectable preparation phase. However, the authors admit that, due to the large number of variables, recognising these signals and using them for medium-term earthquake prediction remains a challenge.

0

Reaction: an early-phase trial with stem cells yields positive results against progressive multiple sclerosis.

The injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well-tolerated, and has a lasting effect that appears to protect the brain against further damage, according to an early-phase trial published today in the journal Cell Stem Cell.

0